{
    "2018-11-13": [
        [
            {
                "time": "2018-11-05",
                "original_text": "Alcon Files Initial Registration Statement With SEC For Proposed Spin-off",
                "features": {
                    "keywords": [
                        "Alcon",
                        "spin-off",
                        "SEC",
                        "registration"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-03-12",
                "original_text": "Jazz Pharmaceuticals: How Are Xyrem and Erwinaze Positioned?",
                "features": {
                    "keywords": [
                        "Jazz Pharmaceuticals",
                        "Xyrem",
                        "Erwinaze",
                        "positioned"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-15",
                "original_text": "Glaxo/Innoviva's Trelegy Ellipta Gets Line Extension in Europe",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "Innoviva",
                        "Trelegy Ellipta",
                        "line extension",
                        "Europe"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-26",
                "original_text": "Tilray (TLRY) to Report Q3 Earnings: What's in the Cards?",
                "features": {
                    "keywords": [
                        "Tilray",
                        "Q3 earnings",
                        "report"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "cannabis"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-26",
                "original_text": "Tilray (TLRY) to Report Q3 Earnings: What's in the Cards?",
                "features": {
                    "keywords": [
                        "Tilray",
                        "Q3 earnings",
                        "report"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "cannabis"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}